IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,663 | -35.2% | 165,860 | +0.3% | 0.00% | -33.3% |
| Q2 2023 | $1,164,022 | +78.3% | 165,344 | +54.8% | 0.00% | +50.0% |
| Q1 2023 | $652,682 | -14.1% | 106,822 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $759,528 | -37.1% | 118,862 | -5.7% | 0.00% | -50.0% |
| Q3 2022 | $1,208,000 | -18.4% | 126,107 | -5.9% | 0.00% | 0.0% |
| Q2 2022 | $1,480,000 | -21.4% | 134,038 | +18.6% | 0.00% | 0.0% |
| Q1 2022 | $1,882,000 | +450.3% | 113,039 | +531.2% | 0.00% | +300.0% |
| Q4 2021 | $342,000 | -24.8% | 17,909 | -3.0% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | +0.9% | 18,463 | +6.5% | 0.00% | 0.0% |
| Q2 2021 | $451,000 | -18.4% | 17,342 | -0.8% | 0.00% | 0.0% |
| Q1 2021 | $553,000 | -32.7% | 17,475 | -1.4% | 0.00% | -50.0% |
| Q4 2020 | $822,000 | +35.2% | 17,720 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $608,000 | +24.6% | 18,470 | +3.9% | 0.00% | +100.0% |
| Q2 2020 | $488,000 | -91.0% | 17,780 | -90.2% | 0.00% | -94.4% |
| Q1 2020 | $5,412,000 | +14.0% | 180,800 | +5.4% | 0.02% | +50.0% |
| Q4 2019 | $4,747,000 | +52.1% | 171,500 | 0.0% | 0.01% | +33.3% |
| Q3 2019 | $3,121,000 | -14.2% | 171,500 | +15.6% | 0.01% | -10.0% |
| Q2 2019 | $3,639,000 | +163.7% | 148,400 | +2.3% | 0.01% | +150.0% |
| Q1 2019 | $1,380,000 | +83.8% | 145,100 | +70.9% | 0.00% | +100.0% |
| Q4 2018 | $751,000 | -20.3% | 84,900 | +1.4% | 0.00% | -33.3% |
| Q3 2018 | $942,000 | -12.0% | 83,700 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,071,000 | -15.5% | 83,700 | +11.6% | 0.00% | -25.0% |
| Q1 2018 | $1,267,000 | +306.1% | 75,000 | +92.3% | 0.00% | +300.0% |
| Q4 2017 | $312,000 | +3.3% | 39,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $302,000 | +5.2% | 39,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $287,000 | – | 39,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |